Skip to Main Content

Paper Details

Immunotherapy for EBV-Associated Nasopharyngeal Carcinoma.
Crit Rev Oncog
29
2018
Author NameAffiliation
Mengying HongCancer Institute (Key Laboratory of Cancer Prevention and Intervention, The Second Affiliated Hospital, Zhejiang University School of Medicine, China ZJU-university of california los angeles Joint Center for Medical Education and Research, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases
Kejun TangCancer Institute (Key Laboratory of Cancer Prevention and Intervention, The Second Affiliated Hospital, Zhejiang University School of Medicine, China ZJU-university of california los angeles Joint Center for Medical Education and Research, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases
Hongyu DengChinese Academy of Sciences Key Laboratory of Infection and Immunity, Institute of Biophysics, People's Republic of China CAS Center for Excellence in Biomacromolecules, Chinese Academy of Sciences, People's Republic of China University of the Chinese Academy of Sciences
Yushen DuCancer Institute (Key Laboratory of Cancer Prevention and Intervention, The Second Affiliated Hospital, Zhejiang University School of Medicine, China ZJU-university of california los angeles Joint Center for Medical Education and Research, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases
Ren SunCancer Institute (Key Laboratory of Cancer Prevention and Intervention, The Second Affiliated Hospital, Zhejiang University School of Medicine, China ZJU-university of california los angeles Joint Center for Medical Education and Research, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, David Geffen School of Medicine, University of California at Los Angeles
  • 1 - 5

Datasets